Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/21/24 12:04 | 11/20/24 | AIM | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | 11 | P | 136 | 0.3366 | 0 | 404 | 33 | 1,638 | D | ||||||||||||||
11/21/24 12:02 | 11/20/24 | AIM | Health | BioPrd | Biological Products, (No Diag | Appelrouth Stewart | FL | D | 2 | P | 46 | 0.2650 | 0 | 173 | 116 | 322 | D | |||||||||||||||
5/7/24 08:30 | 5/6/24 | AIM | Health | BioPrd | Biological Products, (No Diag | Rodino Peter W III | FL | O | COO,Secr | 2 | P | 25 | 0.3637 | 0 | 69 | 48 | 213 | D | ||||||||||||||
3/22/24 13:30 | 3/21/24 | AIM | Health | BioPrd | Biological Products, (No Diag | Bryan Nancy | FL | D | 1 | P | 15 | 0.3900 | 0 | 38 | 38 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |